Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose bioequivalence study of generic macitentan 10 mg vs reference in healthy Thai volunteers under fasting
TCTR20260610003Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of macitentan (2 arms), sponsored by Bio-innova. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
macitentan
Beyond the preview
Go deeper on TCTR20260610003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260610003.